Literature DB >> 729316

Myelofibrosis presenting as hypermetabolic bone disease by radionuclide imaging in a patient with asplenia.

E E Kim, F H DeLand.   

Abstract

In a patient with myelocytic anemia, hepatomegaly, and metastases suggested by radiographic evidence of sclerosis throughout the pelvis and spine, a liver-spleen scan revealed mild hepatomegaly and an absent splenic image. A bone scan demonstrated diffusely increased activity in all bones, especially in the joint regions. A bone marrow scan showed only hepatic activity but no significant uptake in the bone marrow. Ultrasonography and contrast angiography failed to identify a spleen. The findings from a bone marrow biopsy and a peripheral blood examination indicated myelofibrosis. The implications of an increased concentration of radiopharmaceuticals in bone are briefly discussed.

Entities:  

Mesh:

Year:  1978        PMID: 729316     DOI: 10.1097/00003072-197810000-00011

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Abnormally high diffuse activity on bone scintigram. The importance of exposure time for its recognition.

Authors:  T Fukuda; Y Inoue; H Ochi; H Nakazima; H Sawa; Y Onoyama
Journal:  Eur J Nucl Med       Date:  1982

2.  Metastatic superscan on (99m)Tc-methylene diphosphonate bone scintigraphy in pediatric neuroblastoma.

Authors:  Saurabh Arora; Varun Singh Dhull; Anirban Mukherjee; Shruti Tulsyan; Abhishek Behera; Madhavi Tripathi
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

3.  Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology.

Authors:  Partha Sarathi Chakraborty; Punit Sharma; Sellam Karunanithi; Chandrasekhar Bal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.